Clinical Trials in Salt Lake City

Showing 1641-1660 of 16,694 trials

Decreasing Nightmares in Adults With Narcolepsy

NCT06383806

The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.

NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+3 more

University of Utah80 participantsStarted Apr 2026

Salt Lake City, Utah, United States

Active Not RecruitingPhase 1< 1 mile

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

NCT05552469

Study CDFV890G12101 is an open-label, phase 1b, multicenter study with a randomized two-dose optimization part, and a dose expansion part consisting of three groups evaluating DFV890 in patients with myeloid diseases. The purpose of this study is to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, efficacy and recommended dose for single agent DFV890 in patients with lower risk (LR: very low, low or intermediate risk) myelodysplastic syndromes (LR MDS), lower risk chronic myelomonocytic leukemia (LR CMML) and High-Risk Clonal Cytopenia of Undetermined Significance (HR CCUS).

Myeloid Diseases

Novartis Pharmaceuticals62 participantsStarted May 2023

Stanford, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +23 more locations

Decreasing Nightmares in Adults With Narcolepsy

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Find Trials by Condition in Salt Lake City

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Type 1 Diabetes Extension Study

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections

Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

SuperSaturated Oxygen Comprehensive Observational Registry

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer